Tag Archives: Catherine Pickering

Merck Ventures forms immuno-oncology spin-out company Onctura SA in Geneva, Switzerland

iOnctura is set up to develop a pipeline of assets targeting immunosuppression in the tumour microenvironment The company will progress its portfolio of assets seamlessly into clinical evaluation, in collaboration with one of its shareholders Cancer Research Technology (CRT) The … Read the full press release